The rising need for antacids is primarily driven by key factors such as the growing incidence of gastroesophageal reflux disease, heartburn, indigestion, and other digestive issues. Additionally, ...

This action follows reports from the US Food and Drug Administration (USFDA) of issues concerning broken tablets. The specific medication under scrutiny is Lanthanum Carbonate chewable tablets, ...

You've officially been an adult long enough to introduce an under-eye cream to your skincare routine. View Entire Post › ...

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based arm of Cipla is recalling 1,875 boxes of Lanthanum Carbonate chewable tablets (1000 mg, 10-count bottle) ...

Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high ...

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based arm of Cipla is recalling 1,875 boxes of Lanthanum Carbonate chewable tablets (1000 mg, 10-count bottle) ...

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), US-based arm of Cipla is recalling 1,875 boxes of Lanthanum Carbonate chewable tablets (1000 mg, 10-count bottle) ...

Cipla: Cipla's US-based arm is recalling 1,875 boxes of Lanthanum Carbonate chewable tablets (1,000 mg, 10-count bottle) in the American market, according to the latest enforcement report by the US ...

Data: SHFE, DCE market movement (Nov 22) Domestic aluminum ingot destocking trend may reverse soon Spot prices of lithium carbonate continued to rise Brief Analysis of Silicone Export Data in October ...

Gasgoo Daily: smart #5 kicks off nationwide delivery in China Axera partners with UNISOC in smart AI solution development Schaeffler begins productions of shiftable one-way clutch at Taicang plant ...